Coronavirus | Third phase of vaccination covering persons aged above 50 likely to begin in March

"It is not possible to give an exact date, but we estimate that this process can start in the second, third or the fourth week of March," the Health Minister said.

February 05, 2021 07:28 pm | Updated 10:52 pm IST - New Delhi

"In coming days, 27 crore people who are of above 50 years of age and those under 50 with co-morbidities will be vaccinated," Health Minister Harsh Vardhan said in Lok Sabha.

"In coming days, 27 crore people who are of above 50 years of age and those under 50 with co-morbidities will be vaccinated," Health Minister Harsh Vardhan said in Lok Sabha.

The third phase of vaccination against the coronavirus is likely to commence in March and will cover 27 crore people aged 50 years and above and those with co-morbidities, Health Minister Harsh Vardhan said in Lok Sabha on Friday.

Replying to questions on vaccines and the vaccination drive against the coronavirus during the Question Hour, Mr. Vardhan said nearly five million people have been inoculated in the country so far.

He added that the vaccination drive for frontline workers has begun this week.

"In coming days, 27 crore people who are of above 50 years of age and those under 50 with co-morbidities will be vaccinated," Mr. Vardhan said.

The vaccination drive began on January 16, starting with healthcare workers and then the frontline workers, both estimated to be around three crore.

"After the completion of first and second phases, the third phase could be launched from any week next month," Mr. Vardhan said.

He added that the third phase will cover people above the age of 50.

"It is not possible to give an exact date, but we estimate that this process can start in the second, third or the fourth week of March," he said.

Mr. Vardhan said the Finance Minister has allocated ₹35,000 crore for vaccination in the budget and she has assured that it could be increased if required.

He said two vaccines — Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech — have been approved for emergency use authorisation.

Besides these, work is in progress on seven vaccines. Of the seven, three vaccines are in phase 3 clinical trial stage. Two vaccines are in phase 1 and 2 clinical trial stages and the remaining two are in advanced pre-clinical stage.

He said India has received requests for vaccines from 22 countries. These countries include Afghanistan, Algeria, Bangladesh, Bhutan, Brazil, Egypt, Kuwait, Maldives, Mauritius, Morocco, Mongolia, Myanmar, Nepal, Nicaragua, Oman, Saudi Arabia, Seychelles, South Africa and the U.A.E. There is also request from the Pacific Island countries, he said.

Vaccines have already been given to 15 countries through grant assistance and contracted doses.

He said 56 lakh doses have been sent through grants and five lakh doses through contract.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.